52327 CPT® code: payer coverage and prior authorization3 of 3 payer prior-auth lists that name 52327 require prior authorization or set conditions: Humana, Neighborhood Health Partnership, UnitedHealthcare.
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| Humana | Humana Puerto Rico MA and Dual Medicare-Medicaid | PR | prior auth required | Nov 3, 2025 | Puerto Rico Medicare Advantage and Dual Medicare-Medicaid Plans Preauthorization and Notification List Puerto Rico Medicare Advantage and Dual Medicare-Medicaid Plan Preauthorization and Notification | |
| Neighborhood Health Partnership | Neighborhood Health Partnership | FL | prior auth under conditions | site of care: outpatient hospital; not in AK, IL, GU, MA, PR, RI, TX, UT, VI, WI | Sep 1, 2026 | Prior authorization requirements for Neighborhood Health Partnership Effective September 1, 2026 |
| UnitedHealthcare | UnitedHealthcare Complete (Individual & Family plans) | All | prior auth under conditions | site of care: outpatient hospital | Sep 1, 2026 | Prior authorization requirements for UnitedHealthcare Complete Effective September 1, 2026 |
52327 appears in 7 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross NC, Blue Shield of California, BlueCross BlueShield of South Carolina, Health Care Service Corporation (BCBS IL, TX, OK, NM, MT).
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Bupivacaine Liposome (Exparel) (0941) | listed, no stance (range 50010-53899) | Jul 30, 2026 | payer document |
| Aetna | Vesicoureteral Reflux Treatment by Endoscopic Injection of Bulking Agents (0534) | covered if criteria are met | Jul 30, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Periureteral Bulking Agents As A Treatment Of Vesicoureteral Reflux (A.7.01.102) | covered if criteria are met | payer document | |
| Blue Cross NC | Vesicoureteral Reflux, Treatment with Periureteral Bulking Agents | listed, no stance | Nov 1, 2025 | payer document |
| Blue Shield of California | Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (7.01.102) | listed, no stance | payer document | |
| BlueCross BlueShield of South Carolina | Periureteral Bulking Agents for the Treatment of Vesicoureteral Reflux (VUR) (CAM 701102) | listed, no stance | Oct 1, 2025 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR) (SUR710.022) | listed, no stance | Dec 15, 2025 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.